|
Variables
|
Placebo, n = 32
|
Turmeric, n = 32
|
P1
|
|---|
|
Triglycerides (mg/dL)
|
|
Before
|
176.44 ± 91.96
|
164.34 ± 80.12
|
0.577
|
|
After
|
155.62 ± 85.35
|
141.78 ± 65.57
|
0.470
|
|
P2
|
0.188
|
0.043
| |
|
Total Cholesterol (mg/dL)
|
|
Before
|
194.50 ± 34.29
|
195.88 ± 35.38
|
0.875
|
|
After
|
182.62 ± 29.36
|
186.50 ± 36.49
|
0.641
|
|
P2
|
0.143
|
0.196
| |
|
LDL (mg/dL)
|
|
Before
|
116.52 ± 27.11
|
121.93 ± 28.77
|
0.442
|
|
After
|
104.60 ± 22.99
|
108.40 ± 26.83
|
0.545
|
|
P2
|
0.052
|
0.035
| |
|
HDL (mg/dL)
|
|
Before
|
42.45 ± 10.17
|
40.28 ± 6.66
|
0.316
|
|
After
|
44.59 ± 7.17
|
42.34 ± 4.13
|
0.129
|
|
P2
|
0.247
|
0.049
| |
|
VLDL(mg/dL)
|
|
Before
|
36.17 ± 14.82
|
30.88 ± 15.02
|
0.161
|
|
After
|
33.63 ± 16.55
|
32.53 ± 16.52
|
0.791
|
|
P3
|
0.394
|
0.417
| |
|
Cholesterol/HDL ratio
|
|
Before
|
4.71 ± .0.97
|
5.03 ± 1.37
|
0.294
|
|
After
|
4.16 ± 0.80
|
4.45 ± 1.00
|
0.211
|
|
P2
|
0.012
|
0.021
| |
|
LDL/HDL ratio
|
|
Before
|
2.81 ± 0.72
|
3.12 ± 0.94
|
0.155
|
|
After
|
2.38 ± 0.59
|
2.57 ± 0.66
|
0.235
|
|
P2
|
0.005
|
0.003
| |
|
MDA(mmol/L)
|
|
Before
|
0.278 ± 0.14
|
0.237 ± 0.13
|
0.241
|
|
After
|
0.189 ± 0.13
|
0.167 ± 0.10
|
0.487
|
|
P2
|
0.191
|
0.000
| |
- Values presented as mean ± SD
- NAFLD nonalcoholic fatty liver disease, LDL low-density lipoprotein, HDL high-density lipoprotein, VLDL very low-density lipoprotein, Unit µM/L
- a,bP values indicate differences between the intervention and placebo groups at before and after intervention (Paired T Test)
